NCT04028921
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +11 more
- Locations
-
- Children's Mercy Kansas City Kansas City, Missouri, United States
Clinical trial condition
Insulin Sensitivity
Explore clinical trials studying Insulin Sensitivity. Study availability and eligibility vary by location and protocol.
168 public trials
22 recruiting studies
Insulin Sensitivity trial results
NCT04476160
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +12 more
- Locations
-
- Unit of research in Medical Nutricion, Pediatric Hospital CMN "Siglo XXI" , Instituto Mexicano del Seguro Social México, México City, Mexico
- Instituto Mexicano del Seguro Social Mexico City, Mexico
NCT05791968
- Conditions
- Blood Donation, Ferritin, Glucose Metabolism Disorders, +5 more
- Locations
-
- University of Castilla-La Mancha (Exercise Physiology Lab) Toledo, Spain
NCT03495128
- Conditions
- Atrophy, Behavior, Glucose Metabolism Disorders, +14 more
- Locations
-
- David Greenfield Human Physiology Laboratories Nottingham, Notts, United Kingdom
NCT05421390
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Intolerance, +9 more
- Locations
-
- RI-MUHC Montreal, Quebec, Canada
Completed
Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
NCT04114903
- Conditions
- Body Weight, Cannabis Use, Chemically-Induced Disorders, +19 more
- Locations
-
- Center for Innovation and Creativity Boulder, Colorado, United States
NCT04300049
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- South Texas Veterans Health Care Center San Antonio, Texas, United States
- The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
NCT05195164
- Conditions
- Appetitive Behavior, Behavior, Behavior, Animal, +13 more
- Locations
-
- University of Colorado Aurora, Colorado, United States
NCT04066283
- Conditions
- Appetitive Behavior, Behavior, Behavior, Animal, +13 more
- Locations
-
- University of Colorado Aurora, Colorado, United States
Completed
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
NCT05093517
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
- Locations
-
- Texas Diabetes Institute San Antonio, Texas, United States